Premium
Drug‐Drug Interactions Involving Renal OCT2/MATE Transporters: Clinical Risk Assessment May Require Endogenous Biomarker‐Informed Approach
Author(s) -
Mathialagan Sumathy,
Feng Bo,
Rodrigues A. David,
Varma Manthena V. S.
Publication year - 2021
Publication title -
clinical pharmacology and therapeutics
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.2089
Subject(s) - biomarker , drug , endogeny , transporter , pharmacology , computer science , medicine , chemistry , biochemistry , gene